News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mayne Pharma.
RELATED STOCKHEAD STORIES
News
Rise and Shine: Everything you need to know before the market opens
News
CLOSING BELL: Back from the dead, the ASX delivers in a George A Romero slow-zombie classic
News
CLOSING BELL: Shipments increase after China lifts the ban it never put on Aussie coal
Health & Biotech
ASX Health Stocks: Mayne Pharma launches women contraceptives in US, Oventus’ administrators take over
News
Market Highlights: Another rally before crucial CPI report; and 5 ASX small caps to watch on Thursday
Health & Biotech
ScoPo’s Powerplays: ASX health stocks dancing to a positive tune
Experts
ScoPo’s Powerplays: Calmer week for ASX health stocks with some alarming stats about how many people drink instant coffee
News
Market highlights and 5 ASX small caps to watch on Friday
Experts
ScoPo’s Powerplays: Taps on again with ASX health stocks in BIG capital raises
News
Top 10 at 10: The ASX stocks winning and wilting in early trade Wednesday
News
Market highlights and 5 ASX small caps to watch on Wednesday
Health & Biotech
ASX Health Stocks: INOVIQ reports good study results; Mayne Pharma launches unique oral contraceptive
Health & Biotech
Dr Boreham’s Crucible: Mayne focuses on razzle-dazzle as oral contraceptive approaches the stage
News
Closing Bell: ASX closes slightly lower, still notches up weekly gain
News
Reporting Season Round Up: Most ASX companies reported a solid FY21, but have their fingers crossed for lockdowns to end
Health & Biotech
ASX health stocks: Mayne Pharma slapped with lawsuit, Patrys encounters clinical trial delays
Health & Biotech
